PTC Therapeutics acquires Sangamo's Fabry disease gene therapy for $211M in bankruptcy auction
PTC Therapeutics won the bankruptcy auction for Sangamo Therapeutics' gene therapy assets with a $211 million bid. Sangamo filed for Chapter 11 bankruptcy in June after failing to find strategic alternatives.
2 sourcesGene therapy
00